HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore

Penile Cancer

Penile Cancer

Penile cancer, though rare, is a serious malignancy with significant impacts on male health. Recent advances in cancer research have led to better understanding and management of this condition. Studies have identified key risk factors, such as human papillomavirus (HPV) infection, smoking, and poor hygiene. Research is focusing on HPV vaccination as a preventive measure, highlighting its potential to drastically reduce incidence rates. Innovations in diagnostic techniques, including advanced imaging and molecular markers, enable earlier detection and more precise staging. Additionally, treatment options are evolving, with targeted therapies and immunotherapy showing promise in improving outcomes. Ongoing clinical trials continue to explore novel therapeutic approaches, aiming to enhance survival rates and quality of life for penile cancer patients.

Committee Members
Committee Member - Michael Thompson

Michael Thompson

University of Toronto, Canada
Committee Member - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Committee Member - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States

Submit your abstract Today

YouTube
WhatsAppWhatsApp